Study to Evaluate the Performance and Safety of the MARIAL® in Association With PPI Versus PPI Alone
Status:
Recruiting
Trial end date:
2025-01-31
Target enrollment:
Participant gender:
Summary
Many patients with acid reflux disease do not improve with regular doses of proton pump
inhibitors (e.g., omeprazole). The goals of this clinical trial is the to see if taking
MARIAL®, in combination with omeprazole, for one month improves symptoms of acid reflux
disease compared to taking omeprazole alone.
Furthermore, this study will verify the effectiveness of MARIAL® as a maintenance treatment
for the next five months.
This trial is called by the registered name GENYAL®.